Viewing Study NCT00515034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-02-26 @ 5:46 PM
Study NCT ID: NCT00515034
Status: COMPLETED
Last Update Posted: 2019-03-19
First Post: 2007-08-10
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pneumonia, Ventilator-Associated View
None Pneumonia, Bacterial View
None Pneumonia View
None Abdominal Abscess View
None Bacterial Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Doripenem View
None Imipenem View
None Cilastatin View
None Vancomycin View
None DORIBAX, DORIPREX, FINIBAX, DURAPTA, PRIMAXIN, Anti Bacterial Agents View
None Ileus View
None Hospitalized View
None Fever View